Those main vaccine players in US some has gone up from $5 to $100++..
So the vaccine distributor cant be that far behind

Just patience guys.. vaccine play dphama is just starting only

The market opportunity for a potential COVID-19 vaccine is vast. At an affordable price of $100 per shot, a company that commercializes its vaccine can rake in $1 billion in revenue by producing 10 million doses. Currently, Inovio has the capacity to manufacture up to 1 million doses by year-end.

Tomoro limit up? Vaccine in june according to Bill gates

https://www.bloomberg.com/news/articles/2020-07-26/bill-gates-says-korean-firm-could-make-200m-vaccines-by-june

next bullrun will be lead by phama and dphama.. once vaccine commence distribution

British pharma major AstraZeneca, which has already begun Phase III human trials of its AZD1222 (formerly known as ChAdOx1 nCoV-19) vaccine candidate, signed its tenth supply-and-manufacturing deal earlier this week.

Brazil announced on Saturday it had signed a $127 million agreement to start producing locally the Oxford-AstraZeneca vaccine. The country is slated to initially produce 30 million doses of the vaccine — half by December and half by January of next year, according to a Reuters report.

Earlier this month, the AstraZeneca CEO told a radio station that the vaccine candidate would likely provide protection against Covid-19 for one year.

US firm Moderna Inc, which has already started Phase II trials for its vaccine candidate mRNA-1273, has partnered with drugmaker Catalent Inc to produce 100 million doses starting in the third quarter of 2020. Under the deal, Catalent will also provide packaging and labeling, storage and distribution services to support Moderna's late-stage clinical trial for the vaccine. Catalent is already in partnership with Johnson and Johnson as well as AstraZeneca.

After this $5.. once vaccine found and approved for production or filling in end of the year...

Supplying and distribution of vaccine can be a lucrative business as the demand is from whole msia population..and rest of world...
Dphama produce many generic drug and is already profitable before the vaccine deal is announce..
The original vaccine may cost thousands a shot..
But with oem vaccine or refilling and distribution, the cost cld then be lower..
So once suitable vaccine identified, then phama and dphama will mass filled and distribute..by then the share price will shoot up...
The demand will be more than supply, as whole world population will need to take that vaccine jab..

$2 is before the vaccine distribution deal announce prices..
Now 2.62 is already discounted prices from 3.60..

Monday high chance will rebound...

EPF also buying...net buyer... you say can hold or not? haha

i see most of the generic drug and antibiotics is manufactured by dphama..
even those antibiotics...
the vaccine is just an added bonus....
more to come... after the panic sellers sold.. it will move up...

relax, relax.. tahun depan $5 la...

this is the same question someone ask last week, and after that it limit up..

wont go to that, as there is support at 2.60....so now is the time lol...

monday up lol... think all the panic sellers already exit

price will recover once all the panicky trader has sold... after that it will go up..even EPF is net buyer..
and dphama has some fundamental as its making around $50mil profit even before this vaccine deal..

the vaccine target market is msia, then follow by global population... huge potential!

this is the next big trend... vaccine news is there everyday..

This play will continue soon, vaccine is the next play..
After glove is what play? answer = vaccine play...
there will be more news on this vaccine distribution coming..
kyy only wrote bad about this , as he is in gloves! so he has his own agenda...
later once he switch to phama/dphama, he may say nice things about phama/dphama..
just now should added more...

when vaccine ready already, do u think dphama price will still be 2.80?
maybe will shoot up like topglove or supermax....

you believe in the gov or kyy?
gov and KJ say dphama and phama will be the one distributing vaccine..

the vaccine play is what will come after this.. and we are closer to vaccine than ever..

dont listen to kyy.. he wants to buy cheap and protect his glove investment..
but we all know, once vaccine is out.. glove play will be over..
next play is vaccine

rebound..vaccine play should last till next year

can it go above 50 cents? face mask producer

face mask producer in play.. EG...!

https://www.thestar.com.my/news/nation/2020/07/23/covid-19-use-of-face-masks-in-public-areas-to-be-mandatory-from-aug-1-says-ismail-sabri

earlier vaccine play, now face mask play? huat ah!

like oceancash.. facemask counter now all go up

EG beneficiary of the fask mask compulsory ruling...they produce facemask machine...

Soon will be $5.. vaccine play only 2 company monopoly
. Phama and dphama...

Now just beginning.. even epf buying.. they are net buyer...
Vaccine bullrun will last till next year maybe

Vaccine play!

Dow rises 100 points after Pfizer-BioNTech vaccine deal

https://www.cnbc.com/2020/07/21/stock-market-futures-open-to-close-news.html

Those who miss supermax and topglove...
dont want to miss this...still early stage ...
next medical bullrun will be vaccine players...

https://stocknews.my/posts/39198/Duopharma,-Pharmaniaga-to-undertake-fill-and-finish-processes-for-Covid-19-vaccine-—-Khairy

The biggest positive factor is unlike gloves which already more than trippled in price, dphama has yet to even double... so , it sure has plenty of room to grow , once vaccine production and distribution is ready..
And the demand will be from msia , follow by global population! Billions of world population need and waiting for covid vaccine! , thats the potential demand!
Like topglove boss say, demand will far exceed supply .. the same apply even more for vaccine !!

Not everyone need to wear glove, but everyone need vaccine! Think about it!

Vaccine after msia, it will be doing the filling and distribution for whole world..so the potential is limitless

Top glove pe 100x , supermax pe 170x..
Dphama pe is just 37x..
So if dphama is vaccine bull run leader , it could trade at 100x to 170x like gloves leader..
So essily , u cld be looking at TP of $9 to $15 ....once the distribution of vaccine commence...

Maybe koon yew yin already move to this counter..
I wont be surprise

Just keep till next year .. maybe will 10x

Glove play almost over.. now till nxt year = vaccine play!

There is no counter like dphama and phama.. exclusive rights to vaccine distribution for msia

They can earn from exporting vaccine once msian requirement is fullfill..

Power play...once vaccine ready , dphama customer will be the 30mil msian and also the rest of the world..
It can supply to other countries

Once vaccine out this dpharma will be play up like topglove..
As it will be the exclusive supplier of vaccine...

dphama existing manufacturing line will be use to fill and distribute the vaccine..
the original vaccine maker like modena may not be able to cope the production and distribution of the vaccines.. as the demand is too much.. whole world will need it..
thats when dphama can come in.... and catch some of that demand pie...

the glove play is numbered as the vaccine is coming out soon...
hence the next play will be those vaccine producer or OEM of distributor.. dphama is one of them selected to do the distribution etc..
so it may move like glove early on..
dont miss this boat!!

yes... according to KJ only 2 company that is selected to handle and distribute the vaccine... so next year once vaccine is ready, dphama will rise like glove counters...10x...
now price is still low i think..